JP2015500286A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015500286A5 JP2015500286A5 JP2014546003A JP2014546003A JP2015500286A5 JP 2015500286 A5 JP2015500286 A5 JP 2015500286A5 JP 2014546003 A JP2014546003 A JP 2014546003A JP 2014546003 A JP2014546003 A JP 2014546003A JP 2015500286 A5 JP2015500286 A5 JP 2015500286A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- tumor
- malignant
- administration
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 230000002601 intratumoral effect Effects 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566655P | 2011-12-04 | 2011-12-04 | |
| US61/566,655 | 2011-12-04 | ||
| PCT/US2012/067802 WO2013133873A2 (en) | 2011-12-04 | 2012-12-04 | Pharmaceutical compositions of sodium ion and calcium ion and methods for treating cancer, tumor and non-malignancy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016234317A Division JP6659525B2 (ja) | 2011-12-04 | 2016-12-01 | がん、腫瘍、および非悪性疾患を治療するためのナトリウムイオンおよびカルシウムイオンの医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015500286A JP2015500286A (ja) | 2015-01-05 |
| JP2015500286A5 true JP2015500286A5 (enExample) | 2016-01-28 |
Family
ID=49117478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014546003A Pending JP2015500286A (ja) | 2011-12-04 | 2012-12-04 | ナトリウムイオンおよびカルシウムイオンの医薬組成物ならびにがん、腫瘍、および非悪性腫瘍を治療する方法 |
| JP2016234317A Expired - Fee Related JP6659525B2 (ja) | 2011-12-04 | 2016-12-01 | がん、腫瘍、および非悪性疾患を治療するためのナトリウムイオンおよびカルシウムイオンの医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016234317A Expired - Fee Related JP6659525B2 (ja) | 2011-12-04 | 2016-12-01 | がん、腫瘍、および非悪性疾患を治療するためのナトリウムイオンおよびカルシウムイオンの医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9962403B2 (enExample) |
| EP (1) | EP2785357A4 (enExample) |
| JP (2) | JP2015500286A (enExample) |
| CN (1) | CN104244959B (enExample) |
| BR (1) | BR112014013561B1 (enExample) |
| IN (1) | IN2014KN01391A (enExample) |
| MX (1) | MX365308B (enExample) |
| RU (1) | RU2600166C2 (enExample) |
| WO (1) | WO2013133873A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101683635B1 (ko) | 2014-12-29 | 2016-12-09 | 가천대학교 산학협력단 | 락테이트 금속염을 포함하는 암 치료용 약학 조성물 |
| CN113433307A (zh) * | 2020-02-10 | 2021-09-24 | 安派科生物医学科技有限公司 | 用于疾病检测和治疗的新型仪器和方法 |
| CN114984040A (zh) * | 2021-04-28 | 2022-09-02 | 黄永茂 | 调理人体经络生物电的适度氯化氢组分及其应用 |
| BE1030834B1 (fr) * | 2024-01-13 | 2025-01-07 | Yongmao Huang | Une méthode diététique pour réguler le bioélectricité des méridiens avec une solution composée de chlorure d'hydrogène pour le diabète et l'hyperlipidémie |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4224349A (en) * | 1978-11-17 | 1980-09-23 | Gooch Robert C | Meat tenderizing method |
| NZ294553A (en) * | 1995-02-03 | 1999-07-29 | Aeterna Lab Inc | Extracts obtained from centrifuging an aqueous homogenate of whole shark cartilage; production and use |
| US6734018B2 (en) * | 1999-06-07 | 2004-05-11 | Lifenet | Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
| CN1159016C (zh) * | 2001-07-02 | 2004-07-28 | 卜子英 | 一种注射用治疗实体性肿瘤的药物组合物 |
| CN101209344B (zh) * | 2006-12-28 | 2012-07-04 | 赵超英 | 高渗液组合物在制备促进伤口愈合的药物中的应用 |
-
2012
- 2012-12-04 JP JP2014546003A patent/JP2015500286A/ja active Pending
- 2012-12-04 BR BR112014013561-4A patent/BR112014013561B1/pt not_active IP Right Cessation
- 2012-12-04 US US14/361,818 patent/US9962403B2/en not_active Expired - Fee Related
- 2012-12-04 EP EP12870727.0A patent/EP2785357A4/en not_active Withdrawn
- 2012-12-04 WO PCT/US2012/067802 patent/WO2013133873A2/en not_active Ceased
- 2012-12-04 MX MX2014006746A patent/MX365308B/es active IP Right Grant
- 2012-12-04 CN CN201280069015.2A patent/CN104244959B/zh not_active Expired - Fee Related
- 2012-12-04 RU RU2014127148/15A patent/RU2600166C2/ru active
-
2014
- 2014-07-02 IN IN1391KON2014 patent/IN2014KN01391A/en unknown
-
2016
- 2016-12-01 JP JP2016234317A patent/JP6659525B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124436T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
| CY1119616T1 (el) | Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα | |
| BR112015023333A8 (pt) | pirrolbenzodiazepinas e conjugados dos mesmos | |
| NZ710746A (en) | Pyrrolobenzodiazepines and conjugates thereof | |
| BR112012026213A8 (pt) | Compostos de pirrolobenzodiazepinas, conjugado das mesmas, composição farmacêutica compreendendo o conjugado e uso do mesmo para o tratamento de uma doença proliferativa | |
| EA201600204A1 (ru) | Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли | |
| CL2014002726A1 (es) | Compuestos derivados de pirrolopirimidina y purina; composicion farmaceutica; utiles en el tratamiento del cancer (div. sol. 566-14). | |
| UA109464C2 (uk) | Спірооксіндольні антагоністи mdm2 | |
| EA201691059A1 (ru) | Соединения-пептидомиметики и содержащие их конъюгаты антитело-лекарственное средство | |
| CL2016000468A1 (es) | Conjugados anti-dll3 (ligando3 tipo delta) manipulados y métodos de uso. | |
| TWD161529S (zh) | 治療燈 | |
| TR201807411T4 (tr) | DNA-PK inhibitörleri. | |
| PL3791896T3 (pl) | Terapia skojarzona obejmująca przeciwciała przeciwko klaudynie 18.2 do leczenia nowotworu | |
| MX340090B (es) | Analogos de spliceostatina. | |
| MX380370B (es) | Modulador del receptor de androgeno y usos de este. | |
| BR112014031421A2 (pt) | composições para tratamento de câncer e métodos para produção das mesmas | |
| GB201209613D0 (en) | New compounds | |
| DOP2012000063A (es) | (heteroarilmetil) tiohidantoinas sustituidas como drogas anticancer | |
| HUE061596T2 (hu) | Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben | |
| MX350539B (es) | Compuestos de enediino, conjugados de los mismos y sus usos y metodos. | |
| PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
| CL2015001202A1 (es) | Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer. | |
| CL2013003230A1 (es) | Uso de volasertib, una sal o un hidrato del mismo para preparar un medicamento útil en el tratamiento de tumores sólidos avanzados y/o metastásicos. | |
| CL2012003322A1 (es) | Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer. | |
| RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения |